Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels

Empirically derived criteria cast doubt on the clinical significance of antidepressant-placebo differences

(2015) Joanna Moncrieff et al.   Contemporary Clinical Trials

Inflammation and clinical response to treatment in depression: A meta-analysis

(2015) R. Strawbridge et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The effect of proinflammatory cytokines in Cognitive Behavioral Therapy

(2015) Fernanda Pedrotti Moreira et al.   JOURNAL OF NEUROIMMUNOLOGY

A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram

(2015) Pei-Shen Ho et al.   PSYCHONEUROENDOCRINOLOGY

The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery

(2014) Johan Dahl et al.   PSYCHONEUROENDOCRINOLOGY

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

(2013) G. Fond et al.   ACTA PSYCHIATRICA SCANDINAVICA

The Epidemiology of Depression Across Cultures

(2013) Ronald C. Kessler et al.   Annual Review of Public Health

The association between depressive symptoms, cognitive function, and inflammation in major depression

(2013) Jesper Krogh et al.   BRAIN BEHAVIOR AND IMMUNITY

C-reactive protein and cortisol in drug-naïve patients with short-illness-duration first episode major depressive disorder: Possible role of cortisol immunomodulatory action at early stage of the disease

(2013) Wiesław Jerzy Cubała et al.   JOURNAL OF AFFECTIVE DISORDERS

Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis

(2013) Kyoung-Sae Na et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The impact of cognitive behavioral therapy on IL-6 levels in unmedicated women experiencing the first episode of depression: A pilot study

(2013) Marta Gazal et al.   PSYCHIATRY RESEARCH

Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals

(2012) Marie Kim Wium-Andersen et al.   JAMA Psychiatry

Treatment response and cognitive impairment in major depression: Association with C-reactive protein

(2011) Hui Hua Chang et al.   BRAIN BEHAVIOR AND IMMUNITY

The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

(2011) Jonas Hannestad et al.   NEUROPSYCHOPHARMACOLOGY

Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression

(2011) Brian Leonard et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Association of high-sensitivity C-reactive protein with de novo major depression

(2010) Julie A. Pasco et al.   BRITISH JOURNAL OF PSYCHIATRY

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

(2010) Michael Maes   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A Meta-Analysis of Cytokines in Major Depression

(2009) Yekta Dowlati et al.   BIOLOGICAL PSYCHIATRY

Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders?

(2009) Pim Cuijpers et al.   JOURNAL OF CLINICAL PSYCHIATRY

Imbalance between Pro- and Anti-inflammatory Cytokines, and between Th1 and Th2 Cytokines in Depressed Patients: The Effect of Electroacupuncture or Fluoxetine Treatment

(2009) C. Song et al.   PHARMACOPSYCHIATRY

Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study

(2008) D. Gimeno et al.   PSYCHOLOGICAL MEDICINE

A detailed examination of cytokine abnormalities in Major Depressive Disorder

(2007) N.M. Simon et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY